Epigallocatechin-3-gallate suppressed the over-expression of HSP 70 and MDR1 induced by heat shock in SGC 7901

Journal of Chemotherapy

Volumn 20, Issue 3, 2008, Pages 355-360

  Tang, Xiao Yan ^a   Zhu, You Qing ^a,b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Epigallocatechin 3 gallate; Gastric carcinoma; Heat shock; HSP 70; MDR 1; P gp

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; EPIGALLOCATECHIN GALLATE; HEAT SHOCK PROTEIN 70; MULTIDRUG RESISTANCE PROTEIN 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG SENSITIVITY; HEAT SHOCK; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA;

EID: 47349085367     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.3.355     Document Type: Article

References (35)

1. Hsu S, Dickinson DP, Qin H. Inhibition of autoantigen expression by (-)-epigallocatechin-3-gallate (the major constituent of green tea) in normal human ceils. J Pharmacol Exp Ther 2005; 315(2):805-811.
2. Xu Y Ho CT Amin SG et al. Inhibition of tobacco specific nitrosamine-induced lung tumorigenesis in A/ J mice by green tea and its major polyphenol as antioxidants. Cancer Resl992; 52:3875-3879.
3. Yamane T, Takahashi T, Kuwata K, et al. Inhibition of N-methyl-N '-nitro-N-nitrosoguanidine-induced carcinogenesis by - epigallocatechin gallate in the rat glandular stomach. Cancer Res 1995; 55:2081-2084.
4. Stefania P, Shangqin G, Kathryn TK, et al. Green tea polyphenol epigallocatechin-3-gallate inhibits Her-2/Neu signaling proliferation and transformed phenotype of breast cancer cells. Cancer Res 2002; 62:652-655.
5. Sinicrope FA, Hart J, Brasitus TA, et al. Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and diseases relapse [J]. Cancer 1994; 74:2908-2910.
6. Van der Holt Lowenberg B, Burnett AK, et al. The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis [J]. Blood 2005; 106:2646-2654.
7. Massa C, Guiducci C, Arioti I, et al. Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70. Cancer Res 2004; 64(4):1502-1508.
8. Wadhwa R, Takano S, Taira K, et al. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells. J Gene Med 2004; 4:439-444.
9. Novoselov SS, Verbova MV, Vasil'eva EV, et al. Expression of Hsp70 and Hdj1 chaperone proteins in human tumor cells Vopr Onkol 2004; 50(2): 174-178.
10. Zierhut B, Mechtler K, Gartner W, et al. Heat shock protein 70 (Hsp70) subtype expression in neuroendocrine tissue and identification of a neuroendocrine tumour-specific Hsp70 truncation. Endocr Relat Cancer 2004; 11(2): 377-389.
11. Bertram J, Palfner K, Hiddemann W, et al. Increase of P-glycoprotein-mediated drug resistance by hsp 90 beta [J]. Anticancer Drugs 1996; 7(8):838-845.
12. Vilaboa NE, Galan A, Troyano A, et al. Regulation of multidrug resistance 1 (MDRl)/P-glycoprotein gene expression and activity by heat-shock transcription factor 1 (HSF1) [J], J Biol Chem 2000; 275(32):24970-24976.
13. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants [J]. Biochim Biophys Acta 1976; 455(1): 152-162
14. Chen CJ, Chin JE, Ueda K, et al. Internal duplication and homology with bacterial transport proteins in the MDR1 gene from multidrug-resistant human cells. Cell 1986; 47(3):381-389.
15. Hyde SC, Emsley P, Hartshorn MJ, et al. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Naturel990; 346(6282):362-365.
16. Omote H, Al-Shawi MK. A novel electron paramagnetic resonance approach to determine the mechanism of drug transport by P-glycoprotein. J Biol Chem 2002; 277(47):45688-45694.
17. Leslie EM, Deeley RG, Cole SP. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 2005; 204(3):216-237.
18. Polgar O, Bates SE. ABC transporters in the balance: is there a role in multidrug resistance? Biol Chem Soc Trans 2005; 33(pt1):241-245.
19. Srivastava PK, Menoret A, Basu S, et al. Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world [J]. Immunity. 1998; 8(6): 657-665.
20. Udono H, Srivastava PK. Heat shock protein 70-associated peptides elicit specific cancer immunity [J]. J Exp Med 1993; 178(4): 1391-1396.
21. Breloer M, Marti T, Fleischer B, et al. Isolation of processed, H-2Kb-binding ovalbumin-derived peptides associated with the stress proteins HSP70 and gp96 [J]. Eur J Immunol 1998; 28(3): 1016-1021.
22. Ishii T, Udono H, Yamano T, et al. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96 [J]. J Immunol 1999; 162(3): 1303-1309.
23. Sliutz G, Karlseder J, Tempfer C, et al. Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy [J]. Br J Cancer 1996; 76(42):172-177.
24. Leischer K, Schmidt B, Kastenmuller W, et al. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro. Immunol 2004; 172(1): 162-169.
25. Schorcht J. Hyperthermia in tumor therapy [J]. Radiobiol Radiother (Berl) 1990; 31(5):383-390.
26. Tanaka R, Takahashi H, Uzuka T, at al. Current status of hyperthermia for therapy of brain tumor [J]. Nippon Rinsho 2005; 63 (Suppl 9):483-489.
27. Ozören N, El-Deiry W. Heat shock protects HCT116 and H460 cells from TRAIL-induced apoptosis [J]. Exp Cell Res 2002; 281(2)-.175-181.
28. Kang TB, Liang NC. Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochemical Pharmacology 2000; 54:1013.
29. Hamilton KL, Gupta S, Knowlton AA. Estrogen and regulation of heat shock protein expression in female cardiomyocytes: cross-talk with NF kappa B signaling. J Mol Cell Cardiol 2004; 36(4):577-584.
30. Hilgarth RS, Hong Y, Park- Sarge OK, et al. Insights into the regulation of heat shock transcription factor 1 SUMO-1 modification. J Biol Chem 2003; 303:196-200.
31. Bijur GN, Jope RS. Heat shock transcription factor (Hsf)-4b recruits Brgl during the G1 phase of the cell cycle and regulate the expression of heat shock proteins. Neurochem 2000; 75(6):2401-2408.
32. Wang X, Khaleque MA, Zhao MJ. Phosphorylation of HSF1 by MAPK-activated protein kinase 2 on serine 121 inhibits transcriptional activity and promotes HSP90 binding. J Biol Chem 2006; 281(2):782-791.
33. Afaq F, Ahmad N, Mukhtar H. Suppression of UVB-induced phosphorylation of mitogen-axtivated protein kinases and nuclear factor kappa B by green tea flavonoid in SKH-1 hairless mice [J]. Oncogene 2003; 22(58):9254-9264.
34. Vayalil PK, Elemets CA, Katiyar SK. Trement of flavonoids in hydrophilic cream prevents UVB-inducedoxidation of lipids and protein, deletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin [J]. Carcinogenesis 2003; 24(5):927-936.
35. Gupta S, Hastak K, Afaq F, et al. Essential role of caspases in (-)-epigallicatechin-3-gallat -mediated inhibition of nuclear factor KappaB and induction of apoptosis[J]. Oncogene 2004; 23(14):2507-2522.